Results 241 to 250 of about 9,265,491 (302)
CO<sub>2</sub> Sequestration: A Global Challenge toward Future Opportunities. [PDF]
Rugabirwa B +3 more
europepmc +1 more source
ABSTRACT Background Collaterals are crucial factors that influence the infarct growth rate (IGR). We aimed to determine whether a comprehensive multimodal collateral score (MCS), incorporating collateral assessment at the arterial, tissue, and venous levels, is associated with functional independence and provides incremental prognostic value over ...
Giorgio Busto +12 more
wiley +1 more source
A Critical Review of Imidacloprid Remediation Technologies for Sustainable Environmental Management. [PDF]
Kumaran SSS +4 more
europepmc +1 more source
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin +11 more
wiley +1 more source
Innovative bioreactor designs for enhancing electron transfer, mass transfer, and product yields in microbial electrosynthesis. [PDF]
Mohanty S +5 more
europepmc +1 more source
Screening Routine Clinical Notes for Epilepsy Surgery Candidates Using Large Language Models
ABSTRACT Objective Epilepsy surgery is severely underutilized despite proven efficacy, with substantial under‐referral of eligible patients in routine clinical practice. This study evaluated the potential role of large language models (LLMs) as decision‐support tools for screening unstructured clinical notes to identify epilepsy surgery candidates and ...
Uriel Fennig +9 more
wiley +1 more source
Data-Driven Efficiency Benchmarking for Risk Mitigation: A Data Envelopment Analysis of U.S. Hospitals, 2018-2024. [PDF]
Dolezel D, Sawesi S.
europepmc +1 more source
ABSTRACT Objective Digital technologies hold promise for transforming healthcare by enhancing personalized treatments and offer valuable opportunities to improve patient care. Here, we evaluated several novel, self‐administered, home‐based, digital endpoints for their association with corresponding conventional standard clinical measures (primary) in ...
Arne Mueller +14 more
wiley +1 more source
Sustainable hybrid technologies for diclofenac disposal: from innovation to commercial feasibility. [PDF]
Gutiérrez-Ramírez R +7 more
europepmc +1 more source

